Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$KRTL a channel partner agreement and white label contract with Medflow Inc. (“Medflow”), creator of a cutting-edge computer-vision based telemedicine platform. This exclusive contract allows KRTL to use and apply Medflow's innovative telemedicine technology in the alternative wellness market.
Medflow, an AI-powered telemedicine solution provider, combines best-in-class facial recognition biometrics with next-generation zero-trust security architecture to accurately verify patient identities. Their comprehensive suite of telemedicine tools, designed with security at the forefront, includes features like end-to-end encryption, facial recognition with ID scan, and HIPAA compliance. The platform allows healthcare providers to review and legally sign medical and legal documentation live with the patient, issue prescriptions, and capture patient vitals such as heart rate, blood pressure, breathing, and stress indicators, all using the patient's computer or mobile phone camera.
Daniel Ball, CEO of KRTL Biotech, is excited about this partnership. He states, "Our collaboration with Medflow is a significant step forward in our mission to enhance patient care in the alternative wellness sector. The integration of Medflow's state-of-the-art telemedicine platform will allow us to provide secure and robust health-related services remotely in the alternative wellness market."
Kelly Fenemore, CEO of Medflow, also shares this enthusiasm. "We are thrilled to partner with KRTL Biotech, a company that shares our commitment to innovation and patient care. This partnership reinforces our mission to provide secure and accessible telemedicine services to patients everywhere."
In a strategic move to bolster its cybersecurity capabilities in support of their MedTech expansion, KRTL Biotech has also entered into a channel partner agreement with boutique cybersecurity firm, Seven Cipher Group LLC ("Seven Cipher"). Seven Cipher combines industry-leading technology and methodology to provide comprehensive cloud and endpoint security solutions. Their innovative approach includes AI, machine learning, and behavioral analytics for proactive threat detection and management.
Seven Cipher’s robust vulnerability assessment and management solutions, along with compliance standards such as ISO, NIST, GDPR, SOC2, and others, will ensure a multi-layered security and compliance approach for KRTL's operations. This partnership will enhance KRTL's ability to safeguard its client’s Web2 and Web3 environments from future threats, including AI-assisted intrusions and eventual quantum-based attacks.
Bryant Thornton, CEO of Seven Cipher, recognizes the significance of this alliance. "Our partnership with KRTL Biotech signals the accessibility and attainability of enterprise-level cybersecurity at a small and medium business level in the alternative wellness industry and beyond. With our combined expertise, we are well-positioned to tackle the unique challenges of this rapidly evolving digital landscape."
"Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
About KRTL Holding Group, Inc.
KRTL is a holding company interested in diversifying risk and accessing new markets. KRTL Holding Group Inc. operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp. Each company has its focus on specific industries including bio and Agri-Technology, to International Trade and Distribution of these technologies and services. This strategy allows KRTL Holding Group to capitalize on investment opportunities, and partnerships, creating value for its shareholders. Additional information on KRTL is available online at www.krtlholding.com and www.krtl-icc.com and www.krtlbiotech.com.
$KRTL an innovator and pioneer in developing industry-leading cross-over tradecraft and proprietary technology in the hemp, cannabis, psilocybin, and alternative wellness sectors, announces that its wholly owned subsidiary, KRTL Biotech (“KRTL”), has entered into a channel partner agreement and white label contract with Medflow Inc. (“Medflow”), creator of a cutting-edge computer-vision based telemedicine platform. This exclusive contract allows KRTL to use and apply Medflow's innovative telemedicine technology in the alternative wellness market.
Medflow, an AI-powered telemedicine solution provider, combines best-in-class facial recognition biometrics with next-generation zero-trust security architecture to accurately verify patient identities. Their comprehensive suite of telemedicine tools, designed with security at the forefront, includes features like end-to-end encryption, facial recognition with ID scan, and HIPAA compliance. The platform allows healthcare providers to review and legally sign medical and legal documentation live with the patient, issue prescriptions, and capture patient vitals such as heart rate, blood pressure, breathing, and stress indicators, all using the patient's computer or mobile phone camera.
Daniel Ball, CEO of KRTL Biotech, is excited about this partnership. He states, "Our collaboration with Medflow is a significant step forward in our mission to enhance patient care in the alternative wellness sector. The integration of Medflow's state-of-the-art telemedicine platform will allow us to provide secure and robust health-related services remotely in the alternative wellness market."
Kelly Fenemore, CEO of Medflow, also shares this enthusiasm. "We are thrilled to partner with KRTL Biotech, a company that shares our commitment to innovation and patient care. This partnership reinforces our mission to provide secure and accessible telemedicine services to patients everywhere."
In a strategic move to bolster its cybersecurity capabilities in support of their MedTech expansion, KRTL Biotech has also entered into a channel partner agreement with boutique cybersecurity firm, Seven Cipher Group LLC ("Seven Cipher"). Seven Cipher combines industry-leading technology and methodology to provide comprehensive cloud and endpoint security solutions. Their innovative approach includes AI, machine learning, and behavioral analytics for proactive threat detection and management.
Seven Cipher’s robust vulnerability assessment and management solutions, along with compliance standards such as ISO, NIST, GDPR, SOC2, and others, will ensure a multi-layered security and compliance approach for KRTL's operations. This partnership will enhance KRTL's ability to safeguard its client’s Web2 and Web3 environments from future threats, including AI-assisted intrusions and eventual quantum-based attacks.
Bryant Thornton, CEO of Seven Cipher, recognizes the significance of this alliance. "Our partnership with KRTL Biotech signals the accessibility and attainability of enterprise-level cybersecurity at a small and medium business level in the alternative wellness industry and beyond. With our combined expertise, we are well-positioned to tackle the unique challenges of this rapidly evolving digital landscape."
"Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
About KRTL Holding Group, Inc.
KRTL is a holding company interested in diversifying risk and accessing new markets. KRTL Holding Group Inc. operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp. Each company has its focus on specific industries including bio and Agri-Technology, to International Trade and Distribution of these technologies and services. This strategy allows KRTL Holding Group to capitalize on investment opportunities, and partnerships, creating value for its shareholders. Additional information on KRTL is available online at www.krtlholding.com and www.krtl-icc.com and www.krtlbiotech.com.
$KRTL As a result, KRTL International Corp assisted its partner, Fortune, Nickel, and Gold Inc., successfully advance the exploration on its Gowan and Beck-Ottaway Properties in Ontario through the services of Axiom Exploration Group Ltd. ("Axiom") of Saskatoon, Sask
$KRTL As a result, KRTL International Corp assisted its partner, Fortune, Nickel, and Gold Inc., successfully advance the exploration on its Gowan and Beck-Ottaway Properties in Ontario through the services of Axiom Exploration Group Ltd. ("Axiom") of Saskatoon, Sask
$KRTL Bryant Thornton, CEO of Seven Cipher, recognizes the significance of this alliance. "Our partnership with KRTL Biotech signals the accessibility and attainability of enterprise-level cybersecurity at a small and medium business level in the alternative wellness industry and beyond. With our combined expertise, we are well-positioned to tackle the unique challenges of this rapidly evolving digital landscape."
"Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
$KRTL Seven Cipher Group LLC is a boutique cybersecurity firm that offers comprehensive security solutions designed for Web2 and Web3 environments. The company combines industry-leading technology and methodology to offer real-time, comprehensive analysis across your cloud and endpoint security landscape. Seven Cipher Group LLC is committed to proactively identifying and mitigating threats before they occur. For more information about Seven Cipher Group LLC, visit www.sevencipher.com.
$KRTL Kelly Fenemore, CEO of Medflow, also shares this enthusiasm. "We are thrilled to partner with KRTL Biotech, a company that shares our commitment to innovation and patient care. This partnership reinforces our mission to provide secure and accessible telemedicine services to patients everywhere."
https://seekingalpha.com/pr/19349677-krtl-partnered-to-bring-comprehensive-cloud-and-endpoint-security-and-ai-powered-telemedicine
$KRTL International is a consultation and distribution company focused on technology and innovations to help greater profitability, social governance, and environmental outcomes to increase and support the 2030 Agenda.
$KRTL Axiom utilized the data to complete a full-service package including data acquisition, processing, analysis, technical reporting, and claim management.
$KRTL Partnered to Bring Comprehensive Cloud and Endpoint Security and AI Powered Telemedicine Solutions
https://finance.yahoo.com/news/krtl-partnered-bring-comprehensive-cloud-130000765.html
$KRTL exclusive contract allows KRTL to use and apply Medflow's innovative telemedicine technology in the alternative wellness market.
$KRTL Biotech has also entered into a channel partner agreement with boutique cybersecurity firm, Seven Cipher Group LLC ("Seven Cipher"). Seven Cipher combines industry-leading technology and methodology to provide comprehensive cloud and endpoint security solutions. Their innovative approach includes AI, machine learning, and behavioral analytics for proactive threat detection and management.
https://www.morningstar.com/news/globe-newswire/8847936/krtl-partnered-to-bring-comprehensive-cloud-and-endpoint-security-and-ai-powered-telemedicine-solutions
$KRTL Medflow, an AI-powered telemedicine solution provider, combines best-in-class facial recognition biometrics with next-generation zero-trust security architecture to accurately verify patient identities. Their comprehensive suite of telemedicine tools, designed with security at the forefront, includes features like end-to-end encryption, facial recognition with ID scan, and HIPAA compliance. The platform allows healthcare providers to review and legally sign medical and legal documentation live with the patient, issue prescriptions, and capture patient vitals such as heart rate, blood pressure, breathing, and stress indicators, all using the patient's computer or mobile phone camera.
Daniel Ball, CEO of KRTL Biotech, is excited about this partnership. He states, "Our collaboration with Medflow is a significant step forward in our mission to enhance patient care in the alternative wellness sector. The integration of Medflow's state-of-the-art telemedicine platform will allow us to provide secure and robust health-related services remotely in the alternative wellness market."
Kelly Fenemore, CEO of Medflow, also shares this enthusiasm. "We are thrilled to partner with KRTL Biotech, a company that shares our commitment to innovation and patient care. This partnership reinforces our mission to provide secure and accessible telemedicine services to patients everywhere."
In a strategic move to bolster its cybersecurity capabilities in support of their MedTech expansion, KRTL Biotech has also entered into a channel partner agreement with boutique cybersecurity firm, Seven Cipher Group LLC ("Seven Cipher"). Seven Cipher combines industry-leading technology and methodology to provide comprehensive cloud and endpoint security solutions. Their innovative approach includes AI, machine learning, and behavioral analytics for proactive threat detection and management.
Seven Cipher’s robust vulnerability assessment and management solutions, along with compliance standards such as ISO, NIST, GDPR, SOC2, and others, will ensure a multi-layered security and compliance approach for KRTL's operations. This partnership will enhance KRTL's ability to safeguard its client’s Web2 and Web3 environments from future threats, including AI-assisted intrusions and eventual quantum-based attacks.
Bryant Thornton, CEO of Seven Cipher, recognizes the significance of this alliance. "Our partnership with KRTL Biotech signals the accessibility and attainability of enterprise-level cybersecurity at a small and medium business level in the alternative wellness industry and beyond. With our combined expertise, we are well-positioned to tackle the unique challenges of this rapidly evolving digital landscape."
"Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
About KRTL Holding Group, Inc.
KRTL is a holding company interested in diversifying risk and accessing new markets. KRTL Holding Group Inc. operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp. Each company has its focus on specific industries including bio and Agri-Technology, to International Trade and Distribution of these technologies and services. This strategy allows KRTL Holding Group to capitalize on investment opportunities, and partnerships, creating value for its shareholders. Additional information on KRTL is available online at www.krtlholding.com and www.krtl-icc.com and www.krtlbiotech.com.
$KRTL news on radar: The Company Has Partnered to Bring Comprehensive Cloud and Endpoint Security and AI Powered Telemedicine Solutions https://finance.yahoo.com/news/krtl-partnered-bring-comprehensive-cloud-130000765.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance
$KRTL ~ KRTL International Corp. had three team members participate as advisors alongside with Park Kyung-il, a professor of horticulture at Yeungnam University, and two professors in the evaluation of the hemp cultivation division of the Industrial Hemp Special Regulatory Free Zone in South Korea.
$RGGI Heading for a big year! “ResGreen is on a streak of sales success, adding another large contract in the second quarter,” said Parsh Patel, ResGreen’s CEO. “Customers are impressed with our cost-effective products that are exceedingly robust and easy to install and maintain, as well as our dedicated customer service.”
$RGGI
$KRTL ~ KRTL International Corp. had three team members participate as advisors alongside with Park Kyung-il, a professor of horticulture at Yeungnam University, and two professors in the evaluation of the hemp cultivation division of the Industrial Hemp Special Regulatory Free Zone in South Korea.
$KRTL ~ KRTL Biotech Inc., a wholly owned subsidiary of KRTL Holding Group, Inc. (OTC: KRTL), is a research and development company that has a focus in the biotechnology space.
$KRTL Recent news can be found here https://www.krtlholding.com/news
$KRTL We are interested in having a competitive edge in the marketplace, through mergers & acquisitions, collaborations, and strategic alliances with specific partners.
$LEAS-$RWOD Merger: 175 $LEAS (.0022) Shares will convert to 1 $RWOD ($10) Share.
175 x .0022 = 0.385. SO $0.385 becomes $10....
Helluva deal huh?...lol
Z
$KRTL Medflow, an AI-powered telemedicine solution provider, combines best-in-class facial recognition biometrics with next-generation zero-trust security architecture to accurately verify patient identities. Their comprehensive suite of telemedicine tools, designed with security at the forefront, includes features like end-to-end encryption, facial recognition with ID scan, and HIPAA compliance. The platform allows healthcare providers to review and legally sign medical and legal documentation live with the patient, issue prescriptions, and capture patient vitals such as heart rate, blood pressure, breathing, and stress indicators, all using the patient's computer or mobile phone camera.
https://www.marketwatch.com/press-release/krtl-partnered-to-bring-comprehensive-cloud-and-endpoint-security-and-ai-powered-telemedicine-solutions-2023-05-30?mod=mw_quote_news_seemore
$KRTL "We are thrilled to partner with KRTL Biotech, a company that shares our commitment to innovation and patient care. This partnership reinforces our mission to provide secure and accessible telemedicine services to patients everywhere."
https://seekingalpha.com/pr/19349677-krtl-partnered-to-bring-comprehensive-cloud-and-endpoint-security-and-ai-powered-telemedicine
$KRTL Seven Cipher’s robust vulnerability assessment and management solutions, along with compliance standards such as ISO, NIST, GDPR, SOC2, and others, will ensure a multi-layered security and compliance approach for KRTL's operations. This partnership will enhance KRTL's ability to safeguard its client’s Web2 and Web3 environments from future threats, including AI-assisted intrusions and eventual quantum-based attacks.
https://www.barrons.com/articles/krtl-partnered-to-bring-comprehensive-cloud-and-endpoint-security-and-ai-powered-telemedicine-solutions-eaa82e6d?mod=md_stockoverview_news
$KRTL Bryant Thornton, CEO of Seven Cipher, recognizes the significance of this alliance. "Our partnership with KRTL Biotech signals the accessibility and attainability of enterprise-level cybersecurity at a small and medium business level in the alternative wellness industry and beyond. With our combined expertise, we are well-positioned to tackle the unique challenges of this rapidly evolving digital landscape."
"Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
$KRTL Seven Cipher Group LLC is a boutique cybersecurity firm that offers comprehensive security solutions designed for Web2 and Web3 environments. The company combines industry-leading technology and methodology to offer real-time, comprehensive analysis across your cloud and endpoint security landscape. Seven Cipher Group LLC is committed to proactively identifying and mitigating threats before they occur. For more information about Seven Cipher Group LLC, visit www.sevencipher.com.
$KRTL Medflow's platform allows healthcare providers to review and legally sign medical and legal documentation live with the patient, issue prescriptions, and capture patient vitals such as heart rate, blood pressure, breathing, and stress indicators, all using the patient's computer or mobile phone camera.
Daniel Ball, CEO of KRTL Biotech, is excited about this partnership. He states, "Our collaboration with Medflow is a significant step forward in our mission to enhance patient care in the alternative wellness sector. The integration of Medflow's state-of-the-art telemedicine platform will allow us to provide secure and robust health-related services remotely in the alternative wellness market."
Kelly Fenemore, CEO of Medflow, also shares this enthusiasm. "We are thrilled to partner with KRTL Biotech, a company that shares our commitment to innovation and patient care. This partnership reinforces our mission to provide secure and accessible telemedicine services to patients everywhere."
In a strategic move to bolster its cybersecurity capabilities in support of their MedTech expansion, KRTL Biotech has also entered into a channel partner agreement with boutique cybersecurity firm, Seven Cipher Group LLC ("Seven Cipher"). Seven Cipher combines industry-leading technology and methodology to provide comprehensive cloud and endpoint security solutions. Their innovative approach includes AI, machine learning, and behavioral analytics for proactive threat detection and management.
Seven Cipher’s robust vulnerability assessment and management solutions, along with compliance standards such as ISO, NIST, GDPR, SOC2, and others, will ensure a multi-layered security and compliance approach for KRTL's operations. This partnership will enhance KRTL's ability to safeguard its client’s Web2 and Web3 environments from future threats, including AI-assisted intrusions and eventual quantum-based attacks.
Bryant Thornton, CEO of Seven Cipher, recognizes the significance of this alliance. "Our partnership with KRTL Biotech signals the accessibility and attainability of enterprise-level cybersecurity at a small and medium business level in the alternative wellness industry and beyond. With our combined expertise, we are well-positioned to tackle the unique challenges of this rapidly evolving digital landscape."
"Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
About KRTL Holding Group, Inc.
KRTL is a holding company interested in diversifying risk and accessing new markets. KRTL Holding Group Inc. operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp. Each company has its focus on specific industries including bio and Agri-Technology, to International Trade and Distribution of these technologies and services. This strategy allows KRTL Holding Group to capitalize on investment opportunities, and partnerships, creating value for its shareholders. Additional information on KRTL is available online at www.krtlholding.com and www.krtl-icc.com and www.krtlbiotech.com.
$KRTL an innovator and pioneer in developing industry-leading cross-over tradecraft and proprietary technology in the hemp, cannabis, psilocybin, and alternative wellness sectors, announces that its wholly owned subsidiary, KRTL Biotech (“KRTL”), has entered into a channel partner agreement and white label contract with Medflow Inc. (“Medflow”), creator of a cutting-edge computer-vision based telemedicine platform. This exclusive contract allows KRTL to use and apply Medflow's innovative telemedicine technology in the alternative wellness market.
Medflow, an AI-powered telemedicine solution provider, combines best-in-class facial recognition biometrics with next-generation zero-trust security architecture to accurately verify patient identities. Their comprehensive suite of telemedicine tools, designed with security at the forefront, includes features like end-to-end encryption, facial recognition with ID scan, and HIPAA compliance. The platform allows healthcare providers to review and legally sign medical and legal documentation live with the patient, issue prescriptions, and capture patient vitals such as heart rate, blood pressure, breathing, and stress indicators, all using the patient's computer or mobile phone camera.
Daniel Ball, CEO of KRTL Biotech, is excited about this partnership. He states, "Our collaboration with Medflow is a significant step forward in our mission to enhance patient care in the alternative wellness sector. The integration of Medflow's state-of-the-art telemedicine platform will allow us to provide secure and robust health-related services remotely in the alternative wellness market."
Kelly Fenemore, CEO of Medflow, also shares this enthusiasm. "We are thrilled to partner with KRTL Biotech, a company that shares our commitment to innovation and patient care. This partnership reinforces our mission to provide secure and accessible telemedicine services to patients everywhere."
In a strategic move to bolster its cybersecurity capabilities in support of their MedTech expansion, KRTL Biotech has also entered into a channel partner agreement with boutique cybersecurity firm, Seven Cipher Group LLC ("Seven Cipher"). Seven Cipher combines industry-leading technology and methodology to provide comprehensive cloud and endpoint security solutions. Their innovative approach includes AI, machine learning, and behavioral analytics for proactive threat detection and management.
Seven Cipher’s robust vulnerability assessment and management solutions, along with compliance standards such as ISO, NIST, GDPR, SOC2, and others, will ensure a multi-layered security and compliance approach for KRTL's operations. This partnership will enhance KRTL's ability to safeguard its client’s Web2 and Web3 environments from future threats, including AI-assisted intrusions and eventual quantum-based attacks.
Bryant Thornton, CEO of Seven Cipher, recognizes the significance of this alliance. "Our partnership with KRTL Biotech signals the accessibility and attainability of enterprise-level cybersecurity at a small and medium business level in the alternative wellness industry and beyond. With our combined expertise, we are well-positioned to tackle the unique challenges of this rapidly evolving digital landscape."
"Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
About KRTL Holding Group, Inc.
KRTL is a holding company interested in diversifying risk and accessing new markets. KRTL Holding Group Inc. operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp. Each company has its focus on specific industries including bio and Agri-Technology, to International Trade and Distribution of these technologies and services. This strategy allows KRTL Holding Group to capitalize on investment opportunities, and partnerships, creating value for its shareholders. Additional information on KRTL is available online at www.krtlholding.com and www.krtl-icc.com and www.krtlbiotech.com.
$KRTL International Corp. had three team members participate as advisors alongside with Park Kyung-il, a professor of horticulture at Yeungnam University, and two professors in the evaluation of the hemp cultivation division of the Industrial Hemp Special Regulatory Free Zone in South Korea.
$KRTL As a result, KRTL International Corp assisted its partner, Fortune, Nickel, and Gold Inc., successfully advance the exploration on its Gowan and Beck-Ottaway Properties in Ontario through the services of Axiom Exploration Group Ltd. ("Axiom") of Saskatoon, Sask
$KRTL As a result, KRTL International Corp assisted its partner, Fortune, Nickel, and Gold Inc., successfully advance the exploration on its Gowan and Beck-Ottaway Properties in Ontario through the services of Axiom Exploration Group Ltd. ("Axiom") of Saskatoon, Sask
$KRTL Kelly Fenemore, CEO of Medflow, also shares this enthusiasm. "We are thrilled to partner with KRTL Biotech, a company that shares our commitment to innovation and patient care. This partnership reinforces our mission to provide secure and accessible telemedicine services to patients everywhere."
https://seekingalpha.com/pr/19349677-krtl-partnered-to-bring-comprehensive-cloud-and-endpoint-security-and-ai-powered-telemedicine
$KRTL Bryant Thornton, CEO of Seven Cipher, recognizes the significance of this alliance. "Our partnership with KRTL Biotech signals the accessibility and attainability of enterprise-level cybersecurity at a small and medium business level in the alternative wellness industry and beyond. With our combined expertise, we are well-positioned to tackle the unique challenges of this rapidly evolving digital landscape."
"Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
$CEI Camber Energy, the company’s Subsidiary Announces Notice of Allowance for Patent Covering Transmission Line Ground Fault Prevention System https://finance.yahoo.com/news/camber-energy-subsidiary-announces-notice-123000947.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance
$KRTL Biotech Inc., a wholly owned subsidiary of KRTL Holding Group, Inc. (OTC: KRTL), is a research and development company that has a focus in the biotechnology space https://www.krtlholding.com/news
$KRTL has entered into a channel partner agreement and white label contract with Medflow Inc. (“Medflow”), creator of a cutting-edge computer-vision based telemedicine platform. This exclusive contract allows KRTL to use and apply Medflow's innovative telemedicine technology in the alternative wellness market.
Medflow, an AI-powered telemedicine solution provider, combines best-in-class facial recognition biometrics with next-generation zero-trust security architecture to accurately verify patient identities. Their comprehensive suite of telemedicine tools, designed with security at the forefront, includes features like end-to-end encryption, facial recognition with ID scan, and HIPAA compliance. The platform allows healthcare providers to review and legally sign medical and legal documentation live with the patient, issue prescriptions, and capture patient vitals such as heart rate, blood pressure, breathing, and stress indicators, all using the patient's computer or mobile phone camera.
Daniel Ball, CEO of KRTL Biotech, is excited about this partnership. He states, "Our collaboration with Medflow is a significant step forward in our mission to enhance patient care in the alternative wellness sector. The integration of Medflow's state-of-the-art telemedicine platform will allow us to provide secure and robust health-related services remotely in the alternative wellness market."
Kelly Fenemore, CEO of Medflow, also shares this enthusiasm. "We are thrilled to partner with KRTL Biotech, a company that shares our commitment to innovation and patient care. This partnership reinforces our mission to provide secure and accessible telemedicine services to patients everywhere."
In a strategic move to bolster its cybersecurity capabilities in support of their MedTech expansion, KRTL Biotech has also entered into a channel partner agreement with boutique cybersecurity firm, Seven Cipher Group LLC ("Seven Cipher"). Seven Cipher combines industry-leading technology and methodology to provide comprehensive cloud and endpoint security solutions. Their innovative approach includes AI, machine learning, and behavioral analytics for proactive threat detection and management.
Seven Cipher’s robust vulnerability assessment and management solutions, along with compliance standards such as ISO, NIST, GDPR, SOC2, and others, will ensure a multi-layered security and compliance approach for KRTL's operations. This partnership will enhance KRTL's ability to safeguard its client’s Web2 and Web3 environments from future threats, including AI-assisted intrusions and eventual quantum-based attacks.
Bryant Thornton, CEO of Seven Cipher, recognizes the significance of this alliance. "Our partnership with KRTL Biotech signals the accessibility and attainability of enterprise-level cybersecurity at a small and medium business level in the alternative wellness industry and beyond. With our combined expertise, we are well-positioned to tackle the unique challenges of this rapidly evolving digital landscape."
"Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
About KRTL Holding Group, Inc.
KRTL is a holding company interested in diversifying risk and accessing new markets. KRTL Holding Group Inc. operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp. Each company has its focus on specific industries including bio and Agri-Technology, to International Trade and Distribution of these technologies and services. This strategy allows KRTL Holding Group to capitalize on investment opportunities, and partnerships, creating value for its shareholders. Additional information on KRTL is available online at www.krtlholding.com and www.krtl-icc.com and www.krtlbiotech.com.
$KRTL is interested in having a competitive edge in the marketplace, through mergers & acquisitions, collaborations, and strategic alliances with specific partners.
$KRTL ~ KRTL Partnered to Bring Comprehensive Cloud and Endpoint Security and AI Powered Telemedicine Solutions
https://finance.yahoo.com/news/krtl-partnered-bring-comprehensive-cloud-130000765.html
$KRTL Mergers & acquisitions company, collaborations, and strategic alliances with specific partners.
https://www.krtlholding.com/about
$KRTL International is a consultation and distribution company focused on technology and innovations to help greater profitability, social governance, and environmental outcomes to increase and support the 2030 Agenda.
$KRTL Partnered to Bring Comprehensive Cloud and Endpoint Security and AI Powered Telemedicine Solutions
https://finance.yahoo.com/news/krtl-partnered-bring-comprehensive-cloud-130000765.html
$KRTL news can be found here https://www.krtlholding.com/news
$KRTL CEO of Seven Cipher, recognizes the significance of this alliance. "Our partnership with KRTL Biotech signals the accessibility and attainability of enterprise-level cybersecurity at a small and medium business level in the alternative wellness industry and beyond. With our combined expertise, we are well-positioned to tackle the unique challenges of this rapidly evolving digital landscape."
"Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
$KRTL Seven Cipher Group LLC is a boutique cybersecurity firm that offers comprehensive security solutions designed for Web2 and Web3 environments. The company combines industry-leading technology and methodology to offer real-time, comprehensive analysis across your cloud and endpoint security landscape. Seven Cipher Group LLC is committed to proactively identifying and mitigating threats before they occur. For more information about Seven Cipher Group LLC, visit www.sevencipher.com.
$KRTL Recent news can be found here https://www.krtlholding.com/news
$KRTL ~ KRTL Biotech Inc., a wholly owned subsidiary of KRTL Holding Group, Inc. (OTC: KRTL), is a research and development company that has a focus in the biotechnology space.
$KRTL Comprehensive Cloud and Endpoint Security and AI Powered Telemedicine Solutions
https://finance.yahoo.com/news/krtl-partnered-bring-comprehensive-cloud-130000765.html
$AITX's Subsidiary, Robotic Assistance Devices, Unleashes RADDOG(TM) 2LE, the Robotic Dog for Law Enforcement Applications
Detroit, Michigan, June 06, 2023 (GLOBE NEWSWIRE) -- Artificial Intelligence Technology Solutions, Inc., (the "Company") (OTCPK:AITX), a global leader in AI-driven security and productivity solutions, along with its wholly owned subsidiary Robotic Assistance Devices, Inc. (RAD) today announced that it is now accepting orders for RADDOG 2LE, the robot dog purpose-built for law enforcement agencies. Limited quantities are available as early as July 2023.
RADDOG 2LE marks a critical evolution of quadruped robotics positioned to improve the capabilities of law enforcement agencies and enable them to apply practical robotics for a variety of tasks. With its agile quadruped (four-legged) design and cutting-edge external accessories, RADDOG 2LE empowers officers to conquer challenging terrain, reach inaccessible areas, and navigate through dangerous environments.
Troy McCanna, RAD's Chief Security Officer and a former FBI Agent with extensive experience as a Multi-Jurisdictional Task Force Coordinator/Supervisor, expressed his appreciation for RADDOG's capabilities. McCanna remarked, "Throughout my tenure with the FBI, I often wished for a solution like RADDOG, which would have offered invaluable foresight into the operational environment before deploying my fellow partners into potentially dangerous situations. I can only imagine the tremendous situational awareness benefits that RADDOG would have provided."
RADDOG 2LE offers law enforcement agencies an exceptional combination of advanced performance features and remarkable affordability. Driven by RAD's 'RADPack LE', this quadruped features RADSoC(TM), the on-board visual analytics and video management system included with all of RAD's AI-powered solutions.
RADPack on RADDOG 2LE offers unique features, specifically including an interactive touch screen located at the front of the quadruped. This interface facilitates smooth, high-definition video communication between remote law enforcement officers and individuals within the robot's vicinity. Complemented by integrated microphones, powerful audio speakers, programmable alert lighting, and front headlights, RADDOG 2LE possesses an array of capabilities to effectively engage with, and capture the attention of those it may confront.
"RADDOG represents the epitome of our achievements and offerings at RAD," said Steve Reinharz, CEO of AITX and RAD. "Its exceptional performance as a 'force multiplier', advanced communication capabilities, sleek design, and comparable low cost should make it very attractive to law enforcement agencies."
The Company noted that additional iterations of the RADDOG platform will be announced over the next several weeks.
RADDOG 2LE is scheduled to begin shipping in late July. Complete specifics of its capabilities, features and other details can be found at www.raddog.ai and www.radsecurity.com.
AITX, through its subsidiary, Robotic Assistance Devices, Inc. (RAD), is redefining the $25 billion (US) security and guarding services industry through its broad lineup of innovative, AI-driven Solutions-as-a-Service business model. RAD solutions are specifically designed to provide a cost savings to businesses of between 35%-80% when compared to the industry's existing and costly manned security guarding and monitoring model. RAD delivers this tremendous costs savings via a suite of stationary and mobile robotic solutions that complement, and at times, directly replace the need for human personnel in environments better suited for machines. All RAD technologies, AI-based analytics and software platforms are developed in-house.
RAD has a prospective sales pipeline of over 35 Fortune 500 companies and numerous other client opportunities. RAD expects to continue to attract new business as it converts its existing sales opportunities into deployed clients generating a recurring revenue stream. Each Fortune 500 client has the potential of making numerous reorders over time.
CAUTIONARY DISCLOSURE ABOUT FORWARD-LOOKING STATEMENTS
The information contained in this publication does not constitute an offer to sell or solicit an offer to buy securities of Artificial Intelligence Technology Solutions, Inc. (the "Company"). This publication contains forward-looking statements, which are not guarantees of future performance and may involve subjective judgment and analysis. The information provided herein is believed to be accurate and reliable, however the Company makes no representations or warranties, expressed or implied, as to its accuracy or completeness. The Company has no obligation to provide the recipient with additional updated information. No information in this publication should be interpreted as any indication whatsoever of the Company's future revenues, results of operations, or stock price.
About Artificial Intelligence Technology Solutions (AITX)
AITX is an innovator in the delivery of artificial intelligence-based solutions that empower organizations to gain new insight, solve complex challenges and fuel new business ideas. Through its next-generation robotic product offerings, AITX's RAD, RAD-M and RAD-G companies help organizations streamline operations, increase ROI, and strengthen business. AITX technology improves the simplicity and economics of patrolling and guard services and allows experienced personnel to focus on more strategic tasks. Customers augment the capabilities of existing staff and gain higher levels of situational awareness, all at drastically reduced cost. AITX solutions are well suited for use in multiple industries such as enterprises, government, transportation, critical infrastructure, education, and healthcare. To learn more, visit http://www.aitx.ai, http://www.radsecurity.com,http://www.stevereinharz.com, http://www.radgroup.ai, http://www.raddog.ai, and www.radlightmyway.com, or follow Steve Reinharz on Twitter @SteveReinharz.
###
Steve Reinharz
949-636-7060
@SteveReinharz
$KRTL Medflow, an AI-powered telemedicine solution provider, combines best-in-class facial recognition biometrics with next-generation zero-trust security architecture to accurately verify patient identities. Their comprehensive suite of telemedicine tools, designed with security at the forefront, includes features like end-to-end encryption, facial recognition with ID scan, and HIPAA compliance. The platform allows healthcare providers to review and legally sign medical and legal documentation live with the patient, issue prescriptions, and capture patient vitals such as heart rate, blood pressure, breathing, and stress indicators, all using the patient's computer or mobile phone camera.
https://www.marketwatch.com/press-release/krtl-partnered-to-bring-comprehensive-cloud-and-endpoint-security-and-ai-powered-telemedicine-solutions-2023-05-30?mod=mw_quote_news_seemore
$KRTL Daniel Ball, CEO of KRTL Biotech, is excited about this partnership. He states, "Our collaboration with Medflow is a significant step forward in our mission to enhance patient care in the alternative wellness sector. The integration of Medflow's state-of-the-art telemedicine platform will allow us to provide secure and robust health-related services remotely in the alternative wellness market."
https://www.nasdaq.com/press-release/krtl-partnered-to-bring-comprehensive-cloud-and-endpoint-security-and-ai-powered
$KRTL Partnered to Bring Comprehensive Cloud and Endpoint Security and AI Powered Telemedicine Solutions
https://finance.yahoo.com/news/krtl-partnered-bring-comprehensive-cloud-130000765.html
$KRTL International Corp. had three team members participate as advisors alongside with Park Kyung-il, a professor of horticulture at Yeungnam University, and two professors in the evaluation of the hemp cultivation division of the Industrial Hemp Special Regulatory Free Zone in South Korea.
Followers
|
351
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
29936
|
Created
|
03/26/14
|
Type
|
Free
|
Moderator RichDude | |||
Assistants Let's Roll Value_Investor ChrisTianSurfer jedijazz fast.money BLULLISH |
Posts Today
|
0
|
Posts (Total)
|
29936
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |